The analysis of the genetic alteration of the ETGs suggested that amplification was the main genetic alteration of eight ETGs except for <i>NTRK2</i> and <i>PIK3R1</i>.<h4>Conclusion</h4>MiR-222-3p might be a specific biomarker of basal-like BC. The gene discussed is NTRK2; the disease is breast cancer.